The largest database of trusted experimental protocols

15 protocols using penicillin streptomycin amphotericin b solution

1

Establishment of RCC Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
The most common and aggressive type of RCC exhibits loss of von Hippel-Lindau (VHL) factor and constitutive expression of hypoxic inducible factor (HIF); therefore, we chose 786-O (CRL-1932, ATCC, Germany) cells to establish RCC xenografts. Indeed, 786-O cells are characterized by a truncated form of HIF-1α and absence of VHL. In RCC, when an HIF-1α mutation is present, VEGF is controlled by constitutive expression of HIF-2α [79 (link)]. Cells were cultivated in high glucose RPMI-1640 medium (Sigma-Aldrich, Austria) supplemented with heat-inactivated fetal bovine serum (Gibco, Austria) and 100x penicillin/streptomycin amphotericin B solution (Lonza, Germany) diluted 1:100.
+ Open protocol
+ Expand
2

Breast Cancer Xenograft Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-468 cell line (ATCC, HTB-132) was used for the generation of breast cancer xenografts. Cells were cultivated in high glucose DMEM medium (Sigma-Aldrich, St. Louis, MO, USA) supplemented with heat-inactivated fetal bovine serum (Gibco, Vienna, Austria) and penicillin/streptomycin amphotericin B solution (Lonza, Cologne, Germany).
+ Open protocol
+ Expand
3

Myosatellite Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The growth medium consisted of 20% FBS and 1% PSA antibiotics in Ham’s F-10 nutrient mix. The differentiation medium consisted of 2% FBS and 1% antibiotics (penicillin-streptomycin-amphotericin B solution, Lonza, Swiss) in Dulbecco’s Modified Eagle Medium (Gibco). Hanwoo myosatellite cells were cultured in hypoxic (2% O2, 5% CO2, 93% N2) and normoxic (20% O2, 5% CO2, 75% N2) conditions using growth medium (GM) for proliferation, and differentiation medium (DM) for differentiation. The atmospheric composition of the incubators (Hanwoo myosatellite cells were cultured in CelCuture® CO2 Incubators, ESCO, and Belgian Blue myosatellite cells were cultured in Great CO2 Incubator for Cultured Cells, Sanyo) were set by injecting CO2 and N2 gas. The satellite cells were seeded at 1800 cells/cm2 and incubated in a humidified incubator at 37 ℃. The satellite cells were cultured in GM until confluent on the 96-well plate or T25 flask and then differentiated into muscle myotubes in DM. Cells cultured with GM only were seeded on pre-coated bovine collagen type I flasks, and cells replaced with DM from GM were seeded into pre-coated Matrigel flasks (Cat # 354234, Matrigel® Basement Membrane Matrix, Corning®, Herndon, VA, USA).
+ Open protocol
+ Expand
4

Differentiation of ReN cell-derived NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ReN cell VM human neural progenitor cells (NPCs) were purchased from EMD Millipore (Billerica, MA, USA). The cells were plated onto BD Matrigel (BD Biosciences, San Jose, CA, USA)‐coated T25 cell‐culture flasks (BD Biosciences, San Jose, CA, USA) and maintained in DMEM/F12 (Life Technologies, Grand Island, NY, USA) media supplemented with 2 mg heparin (StemCell Technologies, Vancouver, Canada), 2% (v/v) B27 neural supplement (Life Technologies, Grand Island, NY, USA), 20 mg EGF (Sigma–Aldrich, St Louis, MO, USA), 20 mg bFGF (Stemgent, Cambridge, MA, USA), and 1% (v/v) penicillin/streptomycin/amphotericin‐B solution (Lonza, Hopkinton, MA, USA) in a CO2 cell culture incubator. Cell‐culture media were changed every 3 d until cells were confluent. For 2D neuron/astrocyte differentiation, the cells were plated onto Matrigel‐coated microfluidic devices with DMEM/F12 differentiation media supplemented with 2 mg heparin, 2% (v/v) B27 neural supplement, and 1% (v/v) penicillin/streptomycin/amphotericin‐B solution without growth factors. Differentiation media was changed every 3–4 days.
+ Open protocol
+ Expand
5

Diesel Particulate Matter 2.5 Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diesel particulate matter 2.5 (NIST SRM 1650b, National Institute of Standards and Technology, Gaithersburg, MD) stock solution (PM2.5 stock solution, 10 mg mL−1) was prepared in dimethyl sulfoxide (DMSO, Sigma‐Aldrich, St. Louis, MO) and sonicated for 30 min at room temperature (RT) to disperse the particles in the solution.[29] Afterward, PM2.5 solution was diluted in Dulbecco's modified Eagle medium (DMEM)/F‐12 (Thermo Fisher Scientific, Waltham, MA)‐based differentiation media consisting of: 2 µg mL−1 of heparin (STEMCELL Technologies, Vancouver, Canada); 2% v/v B27 neuronal supplement (Thermo Fisher Scientific); and 1% v/v penicillin–streptomycin–amphotericin‐B solution (Lonza, Basel, Switzerland). The final concentrations were varied depending on experimental settings. For control counterparts, DMEM/F‐12 differentiation medium was employed including 0.1% DMSO, 2 µg mL−1 of heparin, 2% v/v B27, and 1% v/v penicillin–streptomycin–amphotericin‐B solution without PM2.5 component.
+ Open protocol
+ Expand
6

Cell Culture Protocols for Various Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
All media were supplemented with heat-inactivated fetal bovine serum (Gibco, Vienna, Austria) and penicillin/streptomycin amphotericin B solution (Lonza, Cologne, Germany).
All cell lines have been purchased from American Type Culture Collection. NB cell lines SH-SY5Y and SK-N-BE(2) were cultured in a 1:1 mixture of Ham’s F-12 medium (Sigma-Aldrich, Austria) and Eagle’s minimum essential medium (Sigma-Aldrich, Vienna, Austria). The mixture was supplemented with GlutaMAX (Gibco, Vienna, Austria) and MEM nonessential amino acid solution (Sigma-Aldrich).
RCC 786-O cells were cultured in a high glucose RPMI-1640 medium (Sigma-Aldrich), and RCC CAKI-2 cells were grown in McCoy’s 5a medium (Sigma-Aldrich).
The human embryonic kidney cell line HEK293 and the human normal dermal fibroblasts (HDFn) were grown in high glucose Dulbecco’s modified Eagle’s medium DMEM (Sigma-Aldrich), supplemented with GlutaMAX.
+ Open protocol
+ Expand
7

Omicron BA.5.3.1.1.1 Spike-In Virus Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the series of virus spike-in experiments (see below), we used SARS-CoV-2 cell culture isolate Slovakia/SK-BMC-BA43/2022 which was isolated from a COVID-19 patient from Slovakia in July 2022. The virus belongs to the BE.1.1 lineage (alias of BA.5.3.1.1.1; Omicron VOC) and is deposited in the European virus archive GLOBAL (available at https://www.european-virus-archive.com/virus/sars-cov-2-strain-slovakiask-bmc-ba432022-omicron-voc-be11-alias-ba53111). The virus stock was prepared in a Biosafety level 3 containment laboratory (Biomedical Research Center of the Slovak Academy of Sciences, Slovakia) by infecting Vero E6 cells (Vero C1008, ATCC CRL 1586) cultured in Eagle’s minimal essential medium (EMEM, Lonza, Switzerland) supplemented with 5% FBS (GIBCO, USA), Penicillin-Streptomycin-Amphotericin B Solution (10 ml/l, Lonza, Switzerland).
+ Open protocol
+ Expand
8

Neuron and Astrocyte Differentiation of ReN Cell-Derived NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ReN cell VM human neural progenitor cells (NPCs) were purchased from EMD Millipore (Billerica, MA, USA). The cells were plated onto BD Matrigel® (BD Biosciences, San Jose, CA, USA) coated T25 cell culture flasks (BD Biosciences, San Jose, CA, USA) and maintained in DMEM/F12 (Life Technologies, Grand Island, NY, USA) media supplemented with 2 mg heparin (StemCell Technologies, Vancouver, Canada), 2% (v/v) B27 neural supplement (Life Technologies, Grand Island, NY, USA), 20 mg EGF (Sigma-Aldrich, St Louis, MO, USA), 20 mg bFGF (Stemgent, Cambridge, MA, USA) and 1% (v/v) penicillin/streptomycin/amphotericin-B solution (Lonza, Hopkinton, MA, USA) in a CO2 cell culture incubator. Cell culture media were changed every 3 days until cells were confluent. For 2D neuron/astrocyte differentiation, the cells were plated onto Matrigel®-coated microfluidic devices with DMEM/F12 differentiation media supplemented with 2 mg heparin, 2% (v/v) B27 neural supplement, and 1% (v/v) penicillin/streptomycin/amphotericin-B solution without growth factors. One half volume of the differentiation media was changed every 3–4 days for 3–9 weeks. LPS-RS was purchased from InvivoGen (San Diego, CA). LPS-RS was resuspended in dimethylsulphoxide (DMSO; 0.1 mg in 10 ml) followed by 1:10 dilution in differentiation culture medium. This stock solution of 22.2 mM was then diluted for cell treatment experiments.
+ Open protocol
+ Expand
9

Neuron and Astrocyte Differentiation of ReN Cell-Derived NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
ReN cell VM human neural progenitor cells (NPCs) were purchased from EMD Millipore (Billerica, MA, USA). The cells were plated onto BD Matrigel® (BD Biosciences, San Jose, CA, USA) coated T25 cell culture flasks (BD Biosciences, San Jose, CA, USA) and maintained in DMEM/F12 (Life Technologies, Grand Island, NY, USA) media supplemented with 2 mg heparin (StemCell Technologies, Vancouver, Canada), 2% (v/v) B27 neural supplement (Life Technologies, Grand Island, NY, USA), 20 mg EGF (Sigma-Aldrich, St Louis, MO, USA), 20 mg bFGF (Stemgent, Cambridge, MA, USA) and 1% (v/v) penicillin/streptomycin/amphotericin-B solution (Lonza, Hopkinton, MA, USA) in a CO2 cell culture incubator. Cell culture media were changed every 3 days until cells were confluent. For 2D neuron/astrocyte differentiation, the cells were plated onto Matrigel®-coated microfluidic devices with DMEM/F12 differentiation media supplemented with 2 mg heparin, 2% (v/v) B27 neural supplement, and 1% (v/v) penicillin/streptomycin/amphotericin-B solution without growth factors. One half volume of the differentiation media was changed every 3–4 days for 3–9 weeks. LPS-RS was purchased from InvivoGen (San Diego, CA). LPS-RS was resuspended in dimethylsulphoxide (DMSO; 0.1 mg in 10 ml) followed by 1:10 dilution in differentiation culture medium. This stock solution of 22.2 mM was then diluted for cell treatment experiments.
+ Open protocol
+ Expand
10

Culturing Human Fetal Neural Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ReNcell CX immortalized cell line (SCC007, Millipore Sigma) derived from the cortical region of human fetal brain tissue was cultured to commit into neural progenitor cells (NPCs) according to the supplier’s protocol. The cells were plated onto BD Matrigel-coated T25 cell culture flasks (BD Biosciences, San Jose, CA, USA) and maintained in DMEM/F12 (Life Technologies, Grand Island, NY, USA) media supplemented with 2 μg ml−1 heparin (StemCell Technologies, Vancouver, Canada), 2% (v/v) B27 neural supplement (Life Technologies, Grand Island, NY, USA), 20 μg ml−1 EGF (Sigma-Aldrich, St Louis, MO, USA), 20 μg ml−1 bFGF (Stemgent, Cambridge, MA, USA), and 1% (v/v) penicillin/streptomycin/amphotericin-b solution (Lonza, Hopkinton, MA, USA) in 5% CO2 incubator at 37 °C. Half of the cell culture medium was changed every 3 days until the cells were confluent.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!